Summit Therapeutics (SMMT, $3.86) was one of the top gainers this week, climbing +1 to $3.86 per share. A.I.dvisor analyzed 913 stocks in the Biotechnology Industry over the last week and discovered that of them (5) trended up while of them (4) trended down.